pcDNA-GFP-EphrinB3-Flag
(Plasmid
#155012)
-
PurposeExpresses N-terminally GFP-tagged and C-terminally Flag-tagged EphrinB3 from pcDNA3.1
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 155012 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5500
- Total vector size (bp) 6535
-
Vector typeMammalian Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameEphrinB3
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1035
-
GenBank IDNM_001406.4
-
Entrez GeneEPHB3 (a.k.a. EK2, ETK2, HEK2, TYRO6)
- Promoter CMV
-
Tags
/ Fusion Proteins
- signal peptide (residues 1 to 32) from TGF alpha (N terminal on insert)
- GFP (N terminal on insert)
- Flag (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer T7 forward
- 3′ sequencing primer BGH reverse (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA-GFP-EphrinB3-Flag was a gift from Sinisa Urban (Addgene plasmid # 155012 ; http://n2t.net/addgene:155012 ; RRID:Addgene_155012) -
For your References section:
Designed Parasite-Selective Rhomboid Inhibitors Block Invasion and Clear Blood-Stage Malaria. Gandhi S, Baker RP, Cho S, Stanchev S, Strisovsky K, Urban S. Cell Chem Biol. 2020 Aug 31. pii: S2451-9456(20)30333-0. doi: 10.1016/j.chembiol.2020.08.011. 10.1016/j.chembiol.2020.08.011 PubMed 32888502